Company / Current Assets
Bionano Genomics, Inc. Current Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$45.4M
FY2025
5-year range
$39.5M / $272.4M
FY2021-FY2025
Trend
+14.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets returned to growth in FY2025 after 3 years of decline, reaching $45M.
Based on SEC 10-K filings.
$45M in FY2025 with a 5-year CAGR of -0.6%.
Declined from $140M to $45M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -33.9%
- 5-Year CAGR
- -0.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -0.6%, indicating a declining trend.
- In FY2025, current assets increased 14.9% year-over-year.
- Peak current assets was recorded in FY2021.
- Lowest current assets in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -8.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $45.4M | +14.9% |
| FY2024 | $39.5M | -71.8% |
| FY2023 | $140.1M | -10.9% |
| FY2022 | $157.3M | -42.3% |
| FY2021 | $272.4M | +482.2% |
| FY2020 | $46.8M | +65.6% |
| FY2019 | $28.3M | +22.7% |
| FY2018 | $23.0M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 22, 2026